Table 3. Cox proportional hazard analysis.
| RFS | OS | |||||
|---|---|---|---|---|---|---|
| HR | 95% CI | p value | HR | 95% CI | p value | |
| pStage > II | 1.68 | 1.00–2.83 | 0.052 | 1.84 | 0.85–3.98 | 0.123 |
| EGFR mutation | 1.79 | 1.02–3.15 | 0.041 | 1.39 | 0.65–3.00 | 0.398 |
| Lymphatic invasion | 2.60 | 1.49–4.53 | <0.001 | 2.21 | 1.00–4.91 | 0.051 |
| Vascular invasion | 1.16 | 0.65–2.09 | 0.616 | 1.32 | 0.57–3.06 | 0.520 |
| Micropapillary | 1.57 | 0.84–2.91 | 0.157 | 1.64 | 0.63–4.28 | 0.311 |
| Solid | 1.40 | 0.79–2.49 | 0.246 | 0.94 | 0.43–2.05 | 0.878 |
RFS: recurrence-free survival; OS: overall survival; HR: hazard ratio; CI: confidence interval; pStage: pathological stage; EGFR: epidermal growth factor receptor